Hepatocellular Cancer
Study data from Nagasaki University provide new insights into hepatocellular cancer
Published in Cancer Weekly, January 5th, 2010
"One hundred and forty patients with newly diagnosed HCC were enrolled in the prognosis study. Their fasting serum levels of insulin and adiponectin were determined. Of 140 patients, 59 patients who underwent curative treatment were subjected to analysis of the recurrence-free survival. The 140 patients were divided into two groups by the 50th percentile value of insulin...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-01-05)
More Articles from Cancer Weekly
- Burnham Institute
Delivering medicine directly into a tumor - Columbia University's Mailman School of Public Health
Cancer survival disparities for most minority populations increase as cancers become more treatable - Federation of American Societies for Experimental Biology
Scientists take important step toward the proverbial fountain of youth - Journal of the National Cancer Institute
High risk of colorectal, endometrial and Lynch syndrome cancers for MSH6 mutation carriers - Journal of the National Cancer Institute
News brief: Relatives of boys with sexual birth defects not at risk for testicular germ cell cancer - New York Medical College
Research suggests link between infertility, low egg reserve, and breast/ovarian cancer gene BRCA1 - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
